Expand ADAG Menu
ADAG MENU

ADAG Stock Summary and Trading Ideas (Adagene - Ads Each Representing 1.25 | NASDAQ:ADAG)

Charts for Today's Stock Price and Implied Volatility in Adagene - Ads Each Representing 1.25

14-May-2026

Stock Price & Volume | Full Chart

Sentiment

News

Trading Statistics

Key Ratios

Adagene - Ads Each Representing 1.25 (ADAG) Frequently Asked Questions

What does Adagene - Ads Each Representing 1.25 do?

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

What symbol and exchange does Adagene - Ads Each Representing 1.25 shares trade?

Adagene - Ads Each Representing 1.25 trades on the NASDAQ stock market under the symbol ADAG.

What is Adagene - Ads Each Representing 1.25 stock price doing today?

As of May 14, 2026, ADAG stock price declined to $3.66 with 2,085 million shares trading.

What is Adagene - Ads Each Representing 1.25's Beta?

ADAG has a beta of 0.18, meaning it tends to be less sensitive to market movements. ADAG has a correlation of 0.00 to the broad based SPY ETF.

How much is Adagene - Ads Each Representing 1.25 worth?

ADAG has a market cap of $241.83 million. This is considered a Small Cap stock.

How much money does Adagene - Ads Each Representing 1.25 make?

Last quarter Adagene - Ads Each Representing 1.25 reported $8 million in Revenue and -$.24 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.37.

What is the highest and lowest price Adagene - Ads Each Representing 1.25 traded in the last 3 year period?

In the last 3 years, ADAG traded as high as $4.75 and as low as $1.10.

What are the top ETFs holding Adagene - Ads Each Representing 1.25?

The top ETF exchange traded funds that ADAG belongs to (by Net Assets): PGJ.

Is Adagene - Ads Each Representing 1.25 (ADAG) a good investment?

ADAG has outperformed the market in the last year with a return of +112.8%, while the SPY ETF gained +28.7%. In the last 3 month period, ADAG beat the market returning +12.6%, while SPY returned +10.0%. However, in the most recent 2 weeks ADAG has underperformed the stock market by returning +3.1%, while SPY returned +5.1%.

What are the support and resistance levels for Adagene - Ads Each Representing 1.25 (ADAG)?

ADAG support price is $3.49 and resistance is $3.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADAG shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes